A prospective, randomized, double-blind, parallel controlled clinical trial of spleen aminopeptide oral solution for the prevention and treatment of seasonal allergic rhinitis in children

Start Date23 May 2024

Sponsor / Collaborator

Beijing No. 1 Biochemical Pharmaceutical Co., Ltd.

100 Clinical Results associated with Beijing No. 1 Biochemical Pharmaceutical Co., Ltd.

0 Patents (Medical) associated with Beijing No. 1 Biochemical Pharmaceutical Co., Ltd.

Literatures (Medical) associated with Beijing No. 1 Biochemical Pharmaceutical Co., Ltd.

01 Apr 2025·Journal of the American Academy of Dermatology

HPV Genotypes affect the Efficacy of Hyperthermia Therapy for Plantar Warts: A Quality Improvement Study

Article

Author: Qi, Rui-Qun ; Shu, Chun-Mei ; Qiao Pg, Shuai ; Han, Yue ; Zhang, Chun-Min ; Yan Pg, Hong-Wei ; Gao, Yu ; Zhang, Li ; Li, Xue-Qi ; Gao, Xing-Hua ; Zhang, Hai-Hong ; Wang Mm, Hui-Feng ; Ma, Hui ; Yang, Yang ; Ma, Lei ; Chen, Hong-Duo ; Chen, Ri-Xin ; Xu, Gui-Feng ; Li, Ming-Ru ; Jiang, Hai-Jing ; Sun, Xiao-Dong ; Gao, Yun-Qiu ; Han, Xu ; Pei, Li-Hao ; Zhang, Chun-Hong ; Guo, Hao ; Wang, Qiang

01 Jun 2021·Zhongguo shi yan xue ye xue za zhi

[Therapeutic Effect of Spleen Low Molecular Weight Extracts on Leukopenia Caused by Epirubicin in Mice and Its Mechanism].

Article

Author: Zhu, Yun-Lan ; Pei, Jun ; Huang, Ting-Ting ; Wang, Jin ; Zhang, Yu-Ying ; Chu, Ming ; Zheng, Xin-Yue ; Wang, Yue-Dan ; Lin, Yi-Ting ; Yao, Yi-Fan

OBJECTIVETo investigate the therapeutic effect of spleen low molecular weight extracts on epileptics hydrochloride-induced leukopenia in mice and explore its mechanism.METHODSThe model of leukopenia in mice was established by the injection of epirubicin hydrochloride (10 mg/kg). After the injection of chemotherapeutic drugs, leukocytopenia mice were treated with different doses of spleen low molecular weight extract, Ganoderma oral solution and recombinant granulocyte colony stimulating factor (rhG-CSF). The general survival status indicators such as body weight, coat color and athletic ability of mice in each group were recorded; the tail vein blood of mice in each group was collected and the white blood cell count in them was calculated; bone marrow of mice was taken and bone marrow smears were observed.RESULTSIn the model group, the weight of the mice gradually decreased in the later period, their coat became dark and rough, and the ability to exercise decreased, while the mice in the treatment groups showed different degrees of improvement in their survival status except for the mice treated by rhG-CSF. There was no significant fluctuation in the white blood cell count of the blank control mice. After injection of epirubicin, the white blood cell count of peripheral blood in the model mice and treated mice were decreased. The white blood cell count was lower in the mice treated with high-dose low molecular weight extract and rhG-CSF than that in other experimental groups. Bone marrow smear showed that the proportion of bone marrow nucleated cells in the mice treated with the low molecular weight extract of the spleen was significantly higher than that of model mice (P<0.05).CONCLUSIONThe low molecular weight spleen extracts can significantly improve the hematopoietic state of mouse bone marrow, promote the proliferation of inhibited bone marrow cells, and thus has the effect of treating leukopenia in mice.

100 Deals associated with Beijing No. 1 Biochemical Pharmaceutical Co., Ltd.

100 Translational Medicine associated with Beijing No. 1 Biochemical Pharmaceutical Co., Ltd.

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 15 Apr 2026

No data posted

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Beijing No. 1 Biochemical Pharmaceutical Co., Ltd.

Overview

Related

Corporation Tree

Pipeline

Pipeline Snapshot as of 15 Apr 2026

Deal

Translational Medicine

Profit

Grant & Funding(NIH)

Investment

Financing